Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
Medtronic
Chubb
Johnson and Johnson
Queensland Health
Farmers Insurance
Cantor Fitzgerald
Julphar

Generated: June 23, 2018

DrugPatentWatch Database Preview

ANEXSIA 7.5/325 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Anexsia 7.5/325, and what generic alternatives are available?

Anexsia 7.5/325 is a drug marketed by Specgx Llc and is included in one NDA.

The generic ingredient in ANEXSIA 7.5/325 is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for ANEXSIA 7.5/325
Drug patent expirations by year for ANEXSIA 7.5/325
Pharmacology for ANEXSIA 7.5/325
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for ANEXSIA 7.5/325

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Specgx Llc ANEXSIA 7.5/325 acetaminophen; hydrocodone bitartrate TABLET;ORAL 040405-001 Sep 8, 2000 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
QuintilesIMS
Boehringer Ingelheim
McKinsey
US Army
Citi
Cerilliant
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.